Lipophilic tea polyphenols (LTP) was prepared by esterification of green tea polyphenols (GTP) with hexadecanoyl chloride. A novel long-chain acyl catechin was isolated and purified from LTP by high-speed countercurre...Lipophilic tea polyphenols (LTP) was prepared by esterification of green tea polyphenols (GTP) with hexadecanoyl chloride. A novel long-chain acyl catechin was isolated and purified from LTP by high-speed countercurrent chromatography (HSCCC). Its molecular structure was elucidated as epigallocatechin-3-O-gallate-4'-O-hexadecanate by elemental analysis, IR, MS and H-1 NMR spectra.展开更多
This study demonstrates a new Cellulose diacetate graft b-cyclodextrin(CDA-b-CD)copolymer asymmetric membrane prepared by a phase inversion technique for the separation of(–)-epigallocatechin-3-gallate(EGCG)from othe...This study demonstrates a new Cellulose diacetate graft b-cyclodextrin(CDA-b-CD)copolymer asymmetric membrane prepared by a phase inversion technique for the separation of(–)-epigallocatechin-3-gallate(EGCG)from other polyphenols in crude tea.The graft copolymer,CDA-b-CD,was synthesized by pre-polymerization of cellulose diacetate(CDA)and 1,6-hexamethylene-diisocyanate(HDI),which was then grafted with b-cyclodextrin(b-CD).Surface and cross-section morphologies of the CDA-b-CD membranes were analyzed by using scanning electron microscopy(SEM).Fourier transform infrared spectroscopy(FT-IR)indicated that the b-CD was grafted onto the CDA by chemical bonding.The influences of the HDI/CDA mass ratio and the catalyst mass fraction on the b-CD graft yield were investigated.The optimum conditions of a HDI/CDA mass ratio of 0.35 g$g–1 and a catalyst mass fraction of 0.18 wt-%produced ab-CD graft yield of 26.51 wt-%.The effects of the b-CD graft yield and the concentration of the polymer cast solution on the separation of EGCG were also investigated.Under optimum conditions of a b-CD graft yield of 24.21 wt-%and a polymer concentration of 13 wt-%,the purity of EGCG increased from 26.51 to 86.91 wt-%.展开更多
Background：Green tea has been shown to improve cholesterol metabolism in animal studies,but the molecular mechanisms underlying this function have not been fully understood.Long non-coding RNAs （lncRNAs） have recen...Background：Green tea has been shown to improve cholesterol metabolism in animal studies,but the molecular mechanisms underlying this function have not been fully understood.Long non-coding RNAs （lncRNAs） have recently emerged as a major class of regulatory molecules involved in a broad range of biological processes and complex diseases.Our aim was to identify important lncRNAs that might play an important role in contributing to the benefits of epigallocatechin-3-gallate （EGCG） on cholesterol metabolism.Methods：Microarrays was used to reveal the lncRNA and mRNA profiles in green tea polyphenol（-）-epigallocatechin gallate in cultured human liver （HepG2） hepatocytes treated with EGCG and bioinformatic analyses of the predicted target genes were performed to identify lncRNA-mRNA targeting relationships.RNA interference was used to investigate the role of lncRNAs in cholesterol metabolism.Results：The expression levels of 15 genes related to cholesterol metabolism and 285 lncRNAs were changed by EGCG treatment.Bioinformatic analysis found five matched lncRNA-mRNA pairs for five differentially expressed lncRNAs and four differentially expressed mRNA.In particular,the lncRNA4 T102202 and its potential targets mRNA-3-hydroxy-3-methylglutaryl coenzyme A reductase （HMGCR） were identified.Using a real-time polymerase chain reaction technique,we confirmed that EGCG down-regulated mRNA expression level of the HMGCR and up-regulated expression ofAT102202.After AT102202 knockdown in HepG2,we observed that the level of HMGCR expression was significantly increased relative to the scrambled small interfering RNA control （P 〈 0.05）.Conclusions：Our results indicated that EGCG improved cholesterol metabolism and meanwhile changed the lncRNAs expression profile in HepG2 cells.LncRNAs may play an important role in the cholesterol metabolism.展开更多
Objective To investigate excretion profiles of the four major anti-oxidant active catechins, (-) epigallo-catechin-3-gallate (EGCG), (-) epicatechin-3-gallate (ECG), (-) epigallocatechin (EGC), and epicatechin (EC) in...Objective To investigate excretion profiles of the four major anti-oxidant active catechins, (-) epigallo-catechin-3-gallate (EGCG), (-) epicatechin-3-gallate (ECG), (-) epigallocatechin (EGC), and epicatechin (EC) in tea polyphenols (TP) in rats in order to provide experimental data for clinical uses and development of TP as a novel drug. Methods The above four catechins in urine, bile, and feces were simultaneously determined by high performance liquid chromatography coupled with ultraviolet absorption detector (HPLC-UV) assay with a binary gradient elution. The samples were extracted by ethyl acetate prior to HPLC. The quantification was carried out by peak area internal standard method. Following iv dosing TP 100 mg/kg to rats, the samples were collected at different time intervals up to 8 h (urine and bile) and 24 h (feces). Results The urinary Ae, 0-8 h (cumulative excretion amount over 8 h) of EGCG, ECG, EGC, and EC were, on the average, 150.83, 30.75, 116.69, and 254.56 μg, corresponding to fe, 0-8 h (cumulative excretion fraction of dose over 8 h) of 1.45%, 0.84%, 7.88%, and 10.73%, respectively; the biliary Ae, 0-8 h were 12.61, 42.64, 6.61, and 1.24 μg, corresponding to the fe, 0-8 h of 0.12%, 1.16%, 0.45%, and 0.053%,respectively. For fecal excretion, only EGCG and EGC were detected with Ae, 0-24 h of 7.38 μg (fe, 0-24 h of 0.07%) and 157 μg (fe, 0-24 h of 9.99 %), respectively. The fe, total (the total fe of 3 excretory routes) were 18.32%, 10.78%, 2.00%, and 1.64% for EGC, EC, ECG, and EGCG, respectively. Conclusion EGCG and EC are mainly excreted in urine, ECG in bile, and EGC in feces by reference to their Ae and fe. The excretion of the four catechins based on fe, total is ranked in order of EGC > EC > ECG > EGCG. Only small amount of four catechins are recovered in urine, bile, and feces, indicating an extensive metabolic conversion of catechins in the rat body.展开更多
基金Project supported by the Natural Science Foundation of Zhejiang Province(No.200010).
文摘Lipophilic tea polyphenols (LTP) was prepared by esterification of green tea polyphenols (GTP) with hexadecanoyl chloride. A novel long-chain acyl catechin was isolated and purified from LTP by high-speed countercurrent chromatography (HSCCC). Its molecular structure was elucidated as epigallocatechin-3-O-gallate-4'-O-hexadecanate by elemental analysis, IR, MS and H-1 NMR spectra.
基金gratefully express their appreciation for the financial support obtained from the National Natural Science Foundation of China(Grant No.20636010,20876011 and 20606006)the National Basic Research Program of China(Grant No.2007CB714304)+1 种基金the National High Technology Research and Development Program of China(Grant Nos.2007AA100404,2007AA10Z360)the Beijing key laboratory of bioprocesses.
文摘This study demonstrates a new Cellulose diacetate graft b-cyclodextrin(CDA-b-CD)copolymer asymmetric membrane prepared by a phase inversion technique for the separation of(–)-epigallocatechin-3-gallate(EGCG)from other polyphenols in crude tea.The graft copolymer,CDA-b-CD,was synthesized by pre-polymerization of cellulose diacetate(CDA)and 1,6-hexamethylene-diisocyanate(HDI),which was then grafted with b-cyclodextrin(b-CD).Surface and cross-section morphologies of the CDA-b-CD membranes were analyzed by using scanning electron microscopy(SEM).Fourier transform infrared spectroscopy(FT-IR)indicated that the b-CD was grafted onto the CDA by chemical bonding.The influences of the HDI/CDA mass ratio and the catalyst mass fraction on the b-CD graft yield were investigated.The optimum conditions of a HDI/CDA mass ratio of 0.35 g$g–1 and a catalyst mass fraction of 0.18 wt-%produced ab-CD graft yield of 26.51 wt-%.The effects of the b-CD graft yield and the concentration of the polymer cast solution on the separation of EGCG were also investigated.Under optimum conditions of a b-CD graft yield of 24.21 wt-%and a polymer concentration of 13 wt-%,the purity of EGCG increased from 26.51 to 86.91 wt-%.
基金The present study was supported by a grant from the National Natural Science Foundation of China （No. 81241007）.
文摘Background：Green tea has been shown to improve cholesterol metabolism in animal studies,but the molecular mechanisms underlying this function have not been fully understood.Long non-coding RNAs （lncRNAs） have recently emerged as a major class of regulatory molecules involved in a broad range of biological processes and complex diseases.Our aim was to identify important lncRNAs that might play an important role in contributing to the benefits of epigallocatechin-3-gallate （EGCG） on cholesterol metabolism.Methods：Microarrays was used to reveal the lncRNA and mRNA profiles in green tea polyphenol（-）-epigallocatechin gallate in cultured human liver （HepG2） hepatocytes treated with EGCG and bioinformatic analyses of the predicted target genes were performed to identify lncRNA-mRNA targeting relationships.RNA interference was used to investigate the role of lncRNAs in cholesterol metabolism.Results：The expression levels of 15 genes related to cholesterol metabolism and 285 lncRNAs were changed by EGCG treatment.Bioinformatic analysis found five matched lncRNA-mRNA pairs for five differentially expressed lncRNAs and four differentially expressed mRNA.In particular,the lncRNA4 T102202 and its potential targets mRNA-3-hydroxy-3-methylglutaryl coenzyme A reductase （HMGCR） were identified.Using a real-time polymerase chain reaction technique,we confirmed that EGCG down-regulated mRNA expression level of the HMGCR and up-regulated expression ofAT102202.After AT102202 knockdown in HepG2,we observed that the level of HMGCR expression was significantly increased relative to the scrambled small interfering RNA control （P 〈 0.05）.Conclusions：Our results indicated that EGCG improved cholesterol metabolism and meanwhile changed the lncRNAs expression profile in HepG2 cells.LncRNAs may play an important role in the cholesterol metabolism.
基金support was provided by Dalian Municipal Fund of Science and Technology (2002B4NS044)Kangbosi Pharmaceutical Co. Ltd, China
文摘Objective To investigate excretion profiles of the four major anti-oxidant active catechins, (-) epigallo-catechin-3-gallate (EGCG), (-) epicatechin-3-gallate (ECG), (-) epigallocatechin (EGC), and epicatechin (EC) in tea polyphenols (TP) in rats in order to provide experimental data for clinical uses and development of TP as a novel drug. Methods The above four catechins in urine, bile, and feces were simultaneously determined by high performance liquid chromatography coupled with ultraviolet absorption detector (HPLC-UV) assay with a binary gradient elution. The samples were extracted by ethyl acetate prior to HPLC. The quantification was carried out by peak area internal standard method. Following iv dosing TP 100 mg/kg to rats, the samples were collected at different time intervals up to 8 h (urine and bile) and 24 h (feces). Results The urinary Ae, 0-8 h (cumulative excretion amount over 8 h) of EGCG, ECG, EGC, and EC were, on the average, 150.83, 30.75, 116.69, and 254.56 μg, corresponding to fe, 0-8 h (cumulative excretion fraction of dose over 8 h) of 1.45%, 0.84%, 7.88%, and 10.73%, respectively; the biliary Ae, 0-8 h were 12.61, 42.64, 6.61, and 1.24 μg, corresponding to the fe, 0-8 h of 0.12%, 1.16%, 0.45%, and 0.053%,respectively. For fecal excretion, only EGCG and EGC were detected with Ae, 0-24 h of 7.38 μg (fe, 0-24 h of 0.07%) and 157 μg (fe, 0-24 h of 9.99 %), respectively. The fe, total (the total fe of 3 excretory routes) were 18.32%, 10.78%, 2.00%, and 1.64% for EGC, EC, ECG, and EGCG, respectively. Conclusion EGCG and EC are mainly excreted in urine, ECG in bile, and EGC in feces by reference to their Ae and fe. The excretion of the four catechins based on fe, total is ranked in order of EGC > EC > ECG > EGCG. Only small amount of four catechins are recovered in urine, bile, and feces, indicating an extensive metabolic conversion of catechins in the rat body.
